Abstract:Nuclear transplantation, cell fusion, and induced pluripotent stem cell studies have revealed a surprising degree of plasticity in mature mammalian cell fates. Somatic cell reprogramming also has been achieved more recently by the directed conversion of nonneuronal somatic cells, such as skin fibroblasts, to neuronal phenotypes. This approach appears particularly applicable to the in vitro modeling of human neurologic disorders. Central nervous system neurons are otherwise difficult to obtain from patients with neurologic disorders; however, nonhuman models may not reflect patient pathology. Somatic cell reprogramming may afford models of nonfamilial “sporadic” neurologic disorders, which are likely caused by multiple interacting genetic and nongenetic factors. Directed somatic cell reprogramming, which does not pass through typical in vivo developmental stages, toward many mature neuronal phenotypes has now been described. This article reviews the field and discusses the potential utilities of such models, such as for the development of personalized medicine strategies. Nuclear transplantation, cell fusion, and induced pluripotent stem cell studies have revealed a surprising degree of plasticity in mature mammalian cell fates. Somatic cell reprogramming also has been achieved more recently by the directed conversion of nonneuronal somatic cells, such as skin fibroblasts, to neuronal phenotypes. This approach appears particularly applicable to the in vitro modeling of human neurologic disorders. Central nervous system neurons are otherwise difficult to obtain from patients with neurologic disorders; however, nonhuman models may not reflect patient pathology. Somatic cell reprogramming may afford models of nonfamilial “sporadic” neurologic disorders, which are likely caused by multiple interacting genetic and nongenetic factors. Directed somatic cell reprogramming, which does not pass through typical in vivo developmental stages, toward many mature neuronal phenotypes has now been described. This article reviews the field and discusses the potential utilities of such models, such as for the development of personalized medicine strategies.

Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Direct Conversion of Human Urine Cells to Neurons by Small Molecules

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Modeling neurological diseases using iPSC-derived neural cells

Instant Neurons: Directed Somatic Cell Reprogramming Models of Central Nervous System Disorders

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Fully defined NGN2 neuron protocol reveals diverse signatures of neuronal maturation

Direct conversion of urine-derived cells into functional motor neuron-like cells by defined transcription factors

Efficient and Rapid Conversion of Human Astrocytes and ALS Mouse Model Spinal Cord Astrocytes into Motor Neuron-Like Cells by Defined Small Molecules

Reversing a model of Parkinson's disease with in situ converted nigral neurons

Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Chemical Conversion of Human and Mouse Fibroblasts into Motor Neurons

Generation of Human Neurons by microRNA-Mediated Direct Conversion of Dermal Fibroblasts

Remodeling Neurodegeneration: Somatic Cell Reprogramming-Based Models of Adult Neurological Disorders

Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease

A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line